Is ELV or REGN cheaper?

On trailing earnings, REGN is cheaper: ELV trades at a 17.19 P/E and REGN at 14.92.

Which has grown faster, ELV or REGN?

Over the past five years, REGN grew revenue faster — ELV at a 9.97% CAGR versus REGN at 10.16%.

Does ELV or REGN pay a bigger dividend?

ELV yields 1.70% and REGN yields 0.59% based on trailing dividends and the latest price.

Is ELV or REGN more profitable?

REGN runs the higher net margin — ELV at 2.62% versus REGN at 29.65%.

Which has been the better investment, ELV or REGN?

Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.43% versus REGN at 5.19%. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs Regeneron Pharmaceuticals, Inc. (REGN)

REGN leads on 10 of 16 compared metrics.

A side-by-side comparison of Elevance Health Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Regeneron Pharmaceuticals, Inc.

$63.06B

$612.14Healthcare

Total return — ELV vs REGN

growth of $100 · last 25y

ELV +1875.9%REGN +2801.1%REGN compounded faster

ELV REGN

ELV vs REGN: by the numbers

•ELV is the larger company ($87.75B vs $63.06B market cap).
•REGN trades at the lower earnings multiple (14.92 vs 17.19 P/E).
•REGN converts more revenue to profit (29.65% vs 2.62% net margin).
•REGN grew revenue faster over the past five years (10.16% vs 9.97% CAGR).
•ELV pays the higher dividend yield (1.70% vs 0.59%).

Which is better, ELV or REGN?

Metric tally: ELV 6 · REGN 10

It depends on what you're optimizing for:

ValueREGN(lower P/E)

IncomeELV(higher dividend yield)

QualityREGN(higher ROIC)

Valuation

Metric	ELV	REGN
P/E ratio	17.19	14.92●
Forward P/E	13.82	11.30●
P/S ratio	0.44●	4.42
P/B ratio	2.03●	2.10
PEG ratio	2.58●	3.38
EV / EBITDA	12.48	11.43●
FCF yield	7.24%●	6.30%

Profitability

Metric	ELV	REGN
Gross margin	23.16%	84.55%●
Operating margin	3.81%	24.32%●
Net margin	2.62%	29.65%●
ROE	11.94%	14.08%●
ROIC	6.65%	8.51%●

Dividends

Metric	ELV	REGN
Dividend yield	1.70%●	0.59%
Payout ratio	27.24%	8.45%

Growth (annualized)

Metric	ELV	REGN
Revenue CAGR (5Y)	9.97%	10.16%
EPS CAGR (5Y)	6.67%●	5.70%
FCF CAGR (5Y)	-7.76%	15.42%●
Total return CAGR (5Y)	2.50%	3.26%●

Frequently asked

Which is better, ELV or REGN?: It depends on your goal. value: REGN (lower P/E); income: ELV (higher dividend yield); quality: REGN (higher ROIC). Across all compared metrics, REGN leads 10 to 6.
Is ELV or REGN cheaper?: On trailing earnings, REGN is cheaper: ELV trades at a 17.19 P/E and REGN at 14.92.
Which has grown faster, ELV or REGN?: Over the past five years, REGN grew revenue faster — ELV at a 9.97% CAGR versus REGN at 10.16%.
Does ELV or REGN pay a bigger dividend?: ELV yields 1.70% and REGN yields 0.59% based on trailing dividends and the latest price.
Is ELV or REGN more profitable?: REGN runs the higher net margin — ELV at 2.62% versus REGN at 29.65%.
Which has been the better investment, ELV or REGN?: Over the past 10-year, ELV delivered the higher annualized total return — ELV at 13.43% versus REGN at 5.19%. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full REGN analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio Regeneron Pharmaceuticals P/E ratio Elevance Health dividend yield Regeneron Pharmaceuticals dividend yield Elevance Health ROE Regeneron Pharmaceuticals ROE Elevance Health operating margin Regeneron Pharmaceuticals operating margin Elevance Health revenue growth Regeneron Pharmaceuticals revenue growth Elevance Health free cash flow Regeneron Pharmaceuticals free cash flow

Elevance Health & Regeneron Pharmaceuticals appear in these rankings

Highest FCF Yield Stocks Best 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.